ABEO
insider transactionsABEONA THERAPEUTICS INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-413.0K
0 buy · 413.0K sell
Net value · 365d
-$2.2M
$0 in · $2.2M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
25
0 buy · 413.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·J
Chief Commercial Officer
$1.3K
222 sh · $5.67
-
Sell·S
Director
$103.7K
18.2K sh · $5.71
Own -13%
-
Sell·S
Chief Financial Officer · 10b5-1
$138.3K
25.6K sh · $5.39
Own -5%
-
Sell·S
Chief Financial Officer · 10b5-1
$71.2K
13.4K sh · $5.30
Own -2%
-
Sell·S
Chief Commercial Officer
$28.9K
5.5K sh · $5.30
Own -2%
-
Sell·S
Vishwas Seshadri KEY
Chief Executive Officer
$169.3K
31.9K sh · $5.30
Own -2%
-
Sell·S
SVP, Chief Legal Officer
$33.4K
6.3K sh · $5.30
Own -1%
-
Sell·S
Chief Financial Officer · 10b5-1
$55.8K
10.3K sh · $5.43
Own -2%
-
Sell·S
Chief Commercial Officer
$22.6K
4.2K sh · $5.43
Own -1%
-
Sell·S
Vishwas Seshadri KEY
Chief Executive Officer
$132.6K
24.4K sh · $5.43
Own -2%
-
Sell·S
SVP, Chief Legal Officer
$26.2K
4.8K sh · $5.43
Own -1%
-
Other·G
Director
$0
500 sh
Own -1%
-
Sell·S
Director
$35.5K
6.5K sh · $5.46
Own -8%
-
Sell·S
Director · 10b5-1
$144.6K
26.1K sh · $5.53
Own -41%
-
Sell·S
Chief Commercial Officer
$33.1K
5.5K sh · $5.96
Own -2%
-
Grant·A
Director
$0
32.8K sh
Own New
-
Sell·S
Vishwas Seshadri KEY
Chief Executive Officer · 10b5-1
$131.5K
30.0K sh · $4.38
Own -2%
-
Sell·S
Chief Financial Officer
$3.7K
785 sh · $4.76
Own -0%
-
Sell·S
Director
$75.4K
14.8K sh · $5.09
Own -8%
-
Sell·S
Director
$82.9K
16.3K sh · $5.09
Own -20%
-
Sell·S
Director
$92.0K
18.1K sh · $5.09
Own -9%
-
Sell·S
Director
$10.2K
2.0K sh · $5.09
Own -2%
-
Sell·S
Director
$102.2K
20.1K sh · $5.09
Own -13%
-
Grant·A
Director
$0
37.3K sh
Own +26%
-
Grant·A
Director
$0
37.3K sh
Own +79%
-
Grant·A
Director
$0
37.3K sh
Own +88%
-
Grant·A
Director
$0
37.3K sh
Own +31%
-
Grant·A
Director
$0
37.3K sh
Own +21%
-
Grant·A
Director
$0
37.3K sh
Own +27%
-
Grant·A
Director
$0
37.3K sh
Own +77%
-
Grant·A
Director
$0
37.3K sh
Own +24%
-
Sell·S
Chief Financial Officer
$99.5K
18.7K sh · $5.33
Own -3%
-
Sell·S
Vishwas Seshadri KEY
Chief Executive Officer
$372.3K
69.8K sh · $5.33
Own -5%
-
Sell·S
SVP, Chief Legal Officer
$72.4K
13.6K sh · $5.33
Own -3%
-
Sell·S
Chief Commercial Officer
$66.7K
12.6K sh · $5.29
Own -4%
-
Sell·S
Director
$70.6K
13.5K sh · $5.23
Own -22%
-
Grant·A
Chief Financial Officer
$0
133.6K sh
Own +29%
-
Grant·A
Vishwas Seshadri KEY
Chief Executive Officer
$0
365.4K sh
Own +31%
-
Grant·A
SVP, Chief Legal Officer
$0
113.9K sh
Own +32%
-
Grant·A
Chief Commercial Officer
$0
76.6K sh
Own +30%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Madhav Vasanthavada | Other J | 222 | $1.3K |
| Jun 15, 2026 | Christine Berni Silverstein | Sell S | 18.2K | $103.7K |
| Jun 9, 2026 | Joseph Walter Vazzano KEY 10b5-1 | Sell S | 25.6K | $138.3K |
| Jun 9, 2026 | Joseph Walter Vazzano KEY 10b5-1 | Sell S | 13.4K | $71.2K |
| Jun 9, 2026 | Madhav Vasanthavada | Sell S | 5.5K | $28.9K |
| Jun 9, 2026 | Vishwas Seshadri KEY | Sell S | 31.9K | $169.3K |
| Jun 9, 2026 | Brendan M. O'Malley | Sell S | 6.3K | $33.4K |
| Jun 8, 2026 | Joseph Walter Vazzano KEY 10b5-1 | Sell S | 10.3K | $55.8K |
| Jun 8, 2026 | Madhav Vasanthavada | Sell S | 4.2K | $22.6K |
| Jun 8, 2026 | Vishwas Seshadri KEY | Sell S | 24.4K | $132.6K |
| Jun 8, 2026 | Brendan M. O'Malley | Sell S | 4.8K | $26.2K |
| May 26, 2026 | Mark Alvino | Other G | 500 | $0 |
| May 22, 2026 | Mark Alvino | Sell S | 6.5K | $35.5K |
| May 15, 2026 | Eric Crombez 10b5-1 | Sell S | 26.1K | $144.6K |
| May 11, 2026 | Madhav Vasanthavada | Sell S | 5.5K | $33.1K |
| Apr 1, 2026 | Keith A. Goldan | Grant A | 32.8K | $0 |
| Mar 31, 2026 | Vishwas Seshadri KEY 10b5-1 | Sell S | 30.0K | $131.5K |
| Mar 16, 2026 | Joseph Walter Vazzano KEY | Sell S | 785 | $3.7K |
| Feb 2, 2026 | Donald A. Wuchterl | Sell S | 14.8K | $75.4K |
| Feb 2, 2026 | Eric Crombez | Sell S | 16.3K | $82.9K |
| Feb 2, 2026 | Leila Alland | Sell S | 18.1K | $92.0K |
| Feb 2, 2026 | Mark Alvino | Sell S | 2.0K | $10.2K |
| Feb 2, 2026 | Christine Berni Silverstein | Sell S | 20.1K | $102.2K |
| Jan 26, 2026 | Donald A. Wuchterl | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Bernhardt G Zeiher | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Eric Crombez | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Christine Berni Silverstein | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Michael Amoroso | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Faith L. Charles | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Mark Alvino | Grant A | 37.3K | $0 |
| Jan 26, 2026 | Leila Alland | Grant A | 37.3K | $0 |
| Jan 22, 2026 | Joseph Walter Vazzano KEY | Sell S | 18.7K | $99.5K |
| Jan 22, 2026 | Vishwas Seshadri KEY | Sell S | 69.8K | $372.3K |
| Jan 22, 2026 | Brendan M. O'Malley | Sell S | 13.6K | $72.4K |
| Jan 22, 2026 | Madhav Vasanthavada | Sell S | 12.6K | $66.7K |
| Jan 21, 2026 | Mark Alvino | Sell S | 13.5K | $70.6K |
| Jan 20, 2026 | Joseph Walter Vazzano KEY | Grant A | 133.6K | $0 |
| Jan 20, 2026 | Vishwas Seshadri KEY | Grant A | 365.4K | $0 |
| Jan 20, 2026 | Brendan M. O'Malley | Grant A | 113.9K | $0 |
| Jan 20, 2026 | Madhav Vasanthavada | Grant A | 76.6K | $0 |
About ABEO insider trading
This page tracks insider transactions for ABEONA THERAPEUTICS INC. (ABEO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.